FORA Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

FORA Capital’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,450	Closed	-$247K	–	606
2023 Q3	$247K	Buy	+18,450	New	+$250K	0.02%	408
2023 Q2	–	Sell	-23,005	Closed	-$262K	–	576
2023 Q1	$262K	Buy	+23,005	New	+$248K	0.03%	445
2021 Q3	–	Sell	-2,800	Closed	-$41K	–	757
2021 Q2	$41K	Buy	+2,800	New	+$39.2K	0.01%	746
2020 Q3	–	Sell	-2,340	Closed	-$25K	–	929
2020 Q2	$25K	Sell	2,340 -12,895	-85%	-$131K	0.01%	773
2020 Q1	$123K	Buy	+15,235	New	+$127K	0.03%	563

Other funds holding RDY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

FORA Capital's RDY Position: Q4 2023 in Review

FORA Capital sold out of Dr. Reddy's Laboratories (RDY) in Q4 2023, closing a stake of 18,450 shares — an estimated $247K sold.

FORA Capital first reported a position in RDY in Q1 2020 and held it in 5 quarters. The position peaked at $262K in Q1 2023. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

FORA Capital reported no remaining Dr. Reddy's Laboratories position as of Q4 2023 after selling out during the quarter.
FORA Capital sold 18,450 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $247K.
FORA Capital first reported a position in Dr. Reddy's Laboratories in Q1 2020 and held it in 5 quarters.
FORA Capital's Dr. Reddy's Laboratories position peaked at $262K in Q1 2023.
224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on FORA Capital's 13F filing for Q4 2023, filed 14 Feb 2024.